Italy lifted a ban on Novartis' ($NVS) flu vaccine several weeks after halting distribution due to small particles found in some injections. Other countries, such as Canada and Switzerland, ended a similar ban after accepting that the drugmaker had shown that the vaccines posed no safety risk. Story